Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 1, 2008, Pages 199-213

  Zhao, Ligang ^a   Fang, Liang ^a   Xu, Yongnan ^a   Liu, Shu ^a   He, Zhonggui ^a   Zhao, Yanyan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Lipophilicity; O acylmenthol derivatives; Penetration enhancers; Percutaneous absorption; Saturated fatty acid

Indexed keywords

2 ISOPROPYL 5 METHYLCYCLOHEXYL HEPTANOIC ACID; 2 ISOPROPYL 5 METHYLCYCLOHEXYL HEXANOIC ACID; 2 ISOPROPYL 5 METHYLCYCLOHEXYL TETRADECANOIC ACID; DECANOIC ACID DERIVATIVE; FLUOROURACIL; HEPTANOIC ACID DERIVATIVE; HEXANOIC ACID DERIVATIVE; INDOMETACIN; ISOSORBIDE DINITRATE; KETOPROFEN; LIDOCAINE; MENTHOL; PENETRATION ENHANCING AGENT; SATURATED FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABSORPTION; HYDROPHILICITY; IN VITRO STUDY; LIPOPHILICITY; NONHUMAN; RAT; SKIN; SYNTHESIS;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; FATTY ACIDS; FLUOROURACIL; INDOMETHACIN; ISOSORBIDE DINITRATE; KETOPROFEN; LIDOCAINE; MALE; MENTHOL; RATS; RATS, WISTAR; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL;

EID: 41549100689     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.10.015     Document Type: Article

References (45)

1. Hui X., Wester R.C., Zhai H., and Maibach H.I. Chemical partitioning into powdered human stratum corneum: a useful in vitro model for studying interaction of chemicals and human skin. In: Bronaugh R.L., and Maichach H.I. (Eds). Percutaneous Absorption (2005), Taylor & Francis, Boca Raton 291-302
2. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int. J. Pharm. 184 (1999) 1-6
3. Williams A.C., and Barry B.W. Penetration enhancers. Adv. Drug. Dev. Rev. 56 (2004) 603-618
4. Thakur R.A., Wang Y., and Michniak B.B. Essential oils and terpenes. In: Smith E.W., and Maibach H.I. (Eds). Percutaneous Penetration Enhancers (2006), CRC Press, Boca Raton 159-173
5. Cornwell P.A., and Barry B.W. The routes of penetration of ions and 5-fluorouracil across human skin and the mechanisms of action of terpene skin penetration enhancers. Int. J. Pharm. 94 (1993) 189-194
6. Gao S., and Singh J. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J. Control. Release 51 (1998) 193-199
7. Thomas S., Narishetty K., and Panchagnula R. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J. Control. Release 95 (2004) 367-379
8. Morimoto Y., Wada Y., and Seki T. In vitro permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol. Biol. Pharm. Bull. 25 (2002) 134-136
9. Kobayashi D., Matsuzawa T., and Sugibayashi K. Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menthol-ethanol system on hairless rat and human skin. Biol. Pharm. Bull. 16 (1993) 254-258
10. Negishi J., Takayama K., Higashlyama K., Chida Y., Isowa K., and Nagai T. Promoting effect of O-alkylmenthol and O-acylmenthol derivatives on the percutaneous absorption of ketoprofen in rats. STP Pharma Sci. 5 (1995) 156-161
11. Nakamura Y., Takayama K., Higashiyama K., Suzuki T., and Nagai T. Promoting effect of O-ethylmenthol on the percutaneous absorption of ketoprofen. Int. J. Pharm. 145 (1996) 29-36
12. Takanashi Y., Higashiyama K., Komiya H., Takayama K., and Nagai T. Thiomenthol derivatives as novel percutaneous absorption enhancers. Drug Dev. Ind. Pharm. 25 (1999) 89-94
13. Obata Y., Li C.J., Fujikawa M., Takayama K., Sato H., Higashiyama K., and Nagai T. Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural network. Int. J. Pharm. 212 (2001) 223-231
14. Fuji M., Takeda Y., Yoshida M., Utoguchi N., Matsumoto M., and Watanabe Y. Comparison of skin permeation enhancement by 3-l-menthoxypropane-1,2-diol and l-menthol: the permeation of indomethacin and antipyrine through Yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum. Int. J. Pharm. 258 (2003) 217-233
15. Kirschbaum J. High-pressure liquid chromatography of triamcinolone acetonide: effect of different octadecylsilane columns on mobility. J. Pharm. Sci. 69 (1980) 481-482
16. Li G.F., Quan Y.S., and Fumio K.Y. Influence of different layers of skin on the percutaneous absorption of drugs with different lipophilicity. Chin. Pharm. J. 37 (2002) 833-836
17. a values of clinical used drugs. Anesth. Analg. 71 (1990) 58-70
18. Morimoto Y. Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J. Pharm. Pharmacol. 44 (1992) 634-639
19. H.P. Deppeler, Hydrochlorothiazide, in: K. Florey (Ed.), Analytical profiles of drug substances, Academic press, New York, pp. 443-469.
20. Krevelen V., and Krevelen D.W. Properties of Polymers (1990), Elsevier, Sci. Publ. Co., Amsterdam
21. Hancock B.C., York P., and Rowe R.C. The use of solubility parameters in pharmaceutical solid dosage form design. Int. J. Pharm. 148 (1997) 1-21
22. Fang L., Kobayashi Y., Numajiri S., Kobayashi D., Sugibayashi K., and Morimoto Y. The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol. Pharm. Bull. 25 (2002) 1339-1344
23. Niazy E.M. Differences in penetration-enhancing effect of Azone through excised rabbit, rat, hairless mouse, guinea pig and human skins. Int. J. Pharm. 130 (1996) 225-230
24. Scheuplein R.J. Site variations in diffusion and permeability. In: Jarret A. (Ed). The Physiology and Pathophysiology of Skin (1978), Academic Press, New York 1693-1730
25. Sheth N.V., Freeman D.J., Higuchi W.I., and Spruance S.L. The influence of Azone, propylene glycol and polyethylene glycol on in vitro skin penetration of trifluorothymidine. Int. J. Pharm. 28 (1986) 201-209
26. Guy R.H., and Hadgraft J. Transdermal drug delivery: a simplified pharmacokinetic approach. Int. J. Pharm. 24 (1985) 267-274
27. Fang L., Numajiri S., Kobayashi D., and Morimoto Y. The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid. Int. J. Pharm. 262 (2003) 13-22
28. Izumoto T., Aioi A., Uenoyama S., and Kuriyama S. Relationship between the transference of a drug from a transdermal patch and the physicochemical properties. Chem. Pharm. Bull. 40 (1992) 456-458
29. Monene L.M., Goosen C., Breytenbach J.C., and Hadgraft J. Percutaneous absorption of cyclizine and its alkyl analogues. Eur. J. Pharm. Sci. 24 (2005) 239-244
30. Hori M., Satoh S., Maibach H.I., and Guy R.H. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci 80 (1991) 32-35
31. Wenkers B.P., and Lippold B.C. Skin penetration of non-steroidal anti-inflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis. J. Pharm. Sci. 88 (1999) 1326-1331
32. Williams A.C., and Barry B.W. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm. Res. 8 (1991) 17-24
33. Dias M., Hadgraft J., and Lane M.E. Influence of membrane-solvent-solute interactions on solute permeation in skin. Int. J. Pharm. 340 (2007) 65-70
34. Brodin A., Nyqvist-mayer A., and Wadsten T. Phase diagram and aqueous solubility of lidocaine-prilocaine binary system. J. Pharm. Sci. 73 (1984) 481-484
35. Gao S., and Singh J. Mechanism of transdermal transport of 5-fluorouracil by terpenes: carvone, 1, 8-cineole and thymol. Int. J. Pharm. 154 (1997) 67-77
36. Cornwell P.A., and Barry B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 46 (1994) 261-269
37. Okamoto H., Ohyabu M., Hashida M., and Sezaki H. Enhanced penetration of mitomycin C through hairless mouse and rat skin by enhancers with terpene moieties. J. Pharm. Pharmacol. 39 (1987) 531-534
38. Liron Z., and Cohen S. Percutaneous absorption of alkanoic acids II: application of regular solution theory. J. Pharm. Sci. 73 (1984) 538-542
39. Sekura D.L., and James S. The percutaneous absorption of alkyl methyl sulfoxides. Adv. Biol. Skin 12 (1972) 257-269
40. Cooper E.R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 73 (1984) 1153-1156
41. Kanikkannan N., Kandimalla K., Lamba S.S., and Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem. 7 (2000) 593-608
42. Walters K.A., and Olejnik O.J. Effects of nonionic surfactants on the hairless mouse skin penetration of methyl nicotinate. J. Pharm. Pharmacol. 35 (1983) 79
43. Marjukka S.T., Bouwstra J.A., and Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J. Control. Release 59 (1999) 149-161
44. Cal K., Janicki S., and Sznitowska M. In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin. Int. J. Pharm. 224 (2001) 81-88
45. Cornwell P.A., Barry B.W., Bouwstra J.A., and Gooris G.S. Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. Int. J. Pharm. 127 (1996) 9-26